Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 10236
Country/Region: Zambia
Year: 2018
Main Partner: University Teaching Hospital - Zambia
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $12,549,495 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $500,000
Care: Orphans and Vulnerable Children (HKID) $251,323
Care: TB/HIV (HVTB) $500,000
Care: Pediatric Care and Support (PDCS) $636,847
Laboratory Infrastructure (HLAB) $307,010
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $100,000
Testing: HIV Testing and Counseling (HVCT) $1,043,384
Sexual Prevention: Other Sexual Prevention (HVOP) $95,168
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $515,763
Treatment: Adult Treatment (HTXS) $7,600,000
Treatment: Pediatric Treatment (PDTX) $1,000,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 24
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 155
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 37
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 5
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 34
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 179
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 9
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 44
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 139
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 4
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 94
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 250
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 7
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 9
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 331
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 263
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 737
GEND_GBV Number of people receiving post-GBV care 2019 1,000
HTS_SELF 2019 506
HTS_SELF 10-14, Female, Directly-Assisted 2019 5
HTS_SELF 10-14, Female, Unassisted 2019 10
HTS_SELF 10-14, Male, Directly-Assisted 2019 5
HTS_SELF 10-14, Male, Unassisted 2019 10
HTS_SELF 15-19, Female, Directly-Assisted 2019 15
HTS_SELF 15-19, Female, Unassisted 2019 15
HTS_SELF 15-19, Male, Directly-Assisted 2019 10
HTS_SELF 15-19, Male, Unassisted 2019 10
HTS_SELF 20-24, Female, Directly-Assisted 2019 19
HTS_SELF 20-24, Female, Unassisted 2019 19
HTS_SELF 20-24, Male, Directly-Assisted 2019 19
HTS_SELF 20-24, Male, Unassisted 2019 19
HTS_SELF 25-29, Female, Directly-Assisted 2019 19
HTS_SELF 25-29, Female, Unassisted 2019 19
HTS_SELF 25-29, Male, Directly-Assisted 2019 19
HTS_SELF 25-29, Male, Unassisted 2019 19
HTS_SELF 30-34, Female, Directly-Assisted 2019 19
HTS_SELF 30-34, Female, Unassisted 2019 19
HTS_SELF 30-34, Male, Directly-Assisted 2019 19
HTS_SELF 30-34, Male, Unassisted 2019 19
HTS_SELF 35-39, Female, Directly-Assisted 2019 19
HTS_SELF 35-39, Female, Unassisted 2019 19
HTS_SELF 35-39, Male, Directly-Assisted 2019 19
HTS_SELF 35-39, Male, Unassisted 2019 19
HTS_SELF 40-49, Female, Directly-Assisted 2019 19
HTS_SELF 40-49, Female, Unassisted 2019 19
HTS_SELF 40-49, Male, Directly-Assisted 2019 19
HTS_SELF 40-49, Male, Unassisted 2019 19
HTS_SELF 50+, Female, Directly-Assisted 2019 5
HTS_SELF 50+, Female, Unassisted 2019 6
HTS_SELF 50+, Male, Directly-Assisted 2019 5
HTS_SELF 50+, Male, Unassisted 2019 15
HTS_SELF Directly-Assisted 2019 250
HTS_SELF FSW, Directly-Assisted 2019 150
HTS_SELF FSW, Unassisted 2019 173
HTS_SELF MSM, Directly-Assisted 2019 75
HTS_SELF MSM, Unassisted 2019 94
HTS_SELF Unassisted 2019 256
HTS_SELF Unassisted - Other 2019 64
HTS_SELF Unassisted - Self 2019 128
HTS_SELF Unassisted - Sex Partner 2019 64
HTS_TST <5, Unknown Sex, Negative 2019 110
HTS_TST 1-9, Unknown Sex, Negative 2019 101
HTS_TST 10-14, Female, Negative 2019 17
HTS_TST 10-14, Female, Negative 2019 15
HTS_TST 10-14, Male, Negative 2019 8
HTS_TST 10-14, Male, Negative 2019 12
HTS_TST 15-19, Female, Negative 2019 125
HTS_TST 15-19, Female, Negative 2019 103
HTS_TST 15-19, Male, Negative 2019 36
HTS_TST 15-19, Male, Negative 2019 28
HTS_TST 20-24, Female, Negative 2019 111
HTS_TST 20-24, Female, Negative 2019 90
HTS_TST 20-24, Male, Negative 2019 66
HTS_TST 20-24, Male, Negative 2019 47
HTS_TST 25-29, Female, Negative 2019 64
HTS_TST 25-29, Female, Negative 2019 186
HTS_TST 25-29, Female, Negative 2019 78
HTS_TST 25-29, Female, Negative 2019 11
HTS_TST 25-29, Female, Negative 2019 110
HTS_TST 25-29, Female, Negative 2019 917
HTS_TST 25-29, Female, Negative 2019 6
HTS_TST 25-29, Female, Negative 2019 3,014
HTS_TST 25-29, Female, Negative 2019 49
HTS_TST 25-29, Female, Negative 2019 34
HTS_TST 25-29, Female, Negative 2019 911
HTS_TST 25-29, Female, Negative 2019 27
HTS_TST 25-29, Male, Negative 2019 70
HTS_TST 25-29, Male, Negative 2019 173
HTS_TST 25-29, Male, Negative 2019 83
HTS_TST 25-29, Male, Negative 2019 11
HTS_TST 25-29, Male, Negative 2019 110
HTS_TST 25-29, Male, Negative 2019 922
HTS_TST 25-29, Male, Negative 2019 7
HTS_TST 25-29, Male, Negative 2019 52
HTS_TST 25-29, Male, Negative 2019 35
HTS_TST 25-29, Male, Negative 2019 999
HTS_TST 25-29, Male, Negative 2019 27
HTS_TST 30-34, Female, Negative 2019 64
HTS_TST 30-34, Female, Negative 2019 194
HTS_TST 30-34, Female, Negative 2019 78
HTS_TST 30-34, Female, Negative 2019 11
HTS_TST 30-34, Female, Negative 2019 110
HTS_TST 30-34, Female, Negative 2019 917
HTS_TST 30-34, Female, Negative 2019 6
HTS_TST 30-34, Female, Negative 2019 2,260
HTS_TST 30-34, Female, Negative 2019 49
HTS_TST 30-34, Female, Negative 2019 34
HTS_TST 30-34, Female, Negative 2019 911
HTS_TST 30-34, Female, Negative 2019 27
HTS_TST 30-34, Male, Negative 2019 70
HTS_TST 30-34, Male, Negative 2019 173
HTS_TST 30-34, Male, Negative 2019 83
HTS_TST 30-34, Male, Negative 2019 11
HTS_TST 30-34, Male, Negative 2019 110
HTS_TST 30-34, Male, Negative 2019 922
HTS_TST 30-34, Male, Negative 2019 7
HTS_TST 30-34, Male, Negative 2019 52
HTS_TST 30-34, Male, Negative 2019 35
HTS_TST 30-34, Male, Negative 2019 951
HTS_TST 30-34, Male, Negative 2019 27
HTS_TST 35-39, Female, Negative 2019 64
HTS_TST 35-39, Female, Negative 2019 186
HTS_TST 35-39, Female, Negative 2019 78
HTS_TST 35-39, Female, Negative 2019 11
HTS_TST 35-39, Female, Negative 2019 110
HTS_TST 35-39, Female, Negative 2019 917
HTS_TST 35-39, Female, Negative 2019 6
HTS_TST 35-39, Female, Negative 2019 1,507
HTS_TST 35-39, Female, Negative 2019 49
HTS_TST 35-39, Female, Negative 2019 34
HTS_TST 35-39, Female, Negative 2019 911
HTS_TST 35-39, Female, Negative 2019 27
HTS_TST 35-39, Male, Negative 2019 70
HTS_TST 35-39, Male, Negative 2019 173
HTS_TST 35-39, Male, Negative 2019 83
HTS_TST 35-39, Male, Negative 2019 11
HTS_TST 35-39, Male, Negative 2019 110
HTS_TST 35-39, Male, Negative 2019 922
HTS_TST 35-39, Male, Negative 2019 7
HTS_TST 35-39, Male, Negative 2019 52
HTS_TST 35-39, Male, Negative 2019 35
HTS_TST 35-39, Male, Negative 2019 992
HTS_TST 35-39, Male, Negative 2019 27
HTS_TST 40-49, Female, Negative 2019 64
HTS_TST 40-49, Female, Negative 2019 191
HTS_TST 40-49, Female, Negative 2019 78
HTS_TST 40-49, Female, Negative 2019 11
HTS_TST 40-49, Female, Negative 2019 110
HTS_TST 40-49, Female, Negative 2019 917
HTS_TST 40-49, Female, Negative 2019 6
HTS_TST 40-49, Female, Negative 2019 754
HTS_TST 40-49, Female, Negative 2019 49
HTS_TST 40-49, Female, Negative 2019 34
HTS_TST 40-49, Female, Negative 2019 911
HTS_TST 40-49, Female, Negative 2019 27
HTS_TST 40-49, Male, Negative 2019 70
HTS_TST 40-49, Male, Negative 2019 173
HTS_TST 40-49, Male, Negative 2019 83
HTS_TST 40-49, Male, Negative 2019 11
HTS_TST 40-49, Male, Negative 2019 110
HTS_TST 40-49, Male, Negative 2019 922
HTS_TST 40-49, Male, Negative 2019 7
HTS_TST 40-49, Male, Negative 2019 52
HTS_TST 40-49, Male, Negative 2019 35
HTS_TST 40-49, Male, Negative 2019 951
HTS_TST 40-49, Male, Negative 2019 27
HTS_TST 50+, Female, Negative 2019 86
HTS_TST 50+, Female, Negative 2019 68
HTS_TST 50+, Male, Negative 2019 89
HTS_TST 50+, Male, Negative 2019 63
HTS_TST By Key Population: FSW, Negative 2019 567
HTS_TST By Key Population: MSM, Negative 2019 5
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 22
HTS_TST By Key Population: TG, Negative 2019 2
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 79,821
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 142
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 3
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 11
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 110
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 110
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 110
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 110
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 110
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 110
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 80
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 39
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 8
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 22
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 4
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 18
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 11
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 14
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 14
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 13
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 3
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 13
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 6
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 10
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 39
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 6
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 3
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 59
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 17
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 55
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 27
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 41
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 36
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 77
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 3,148
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 4,352
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 262
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 652
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 108
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 59
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 306
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 143
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 311
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 191
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 266
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 184
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,222
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 199
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 107
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 162
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 42
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 142
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 87
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 112
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 107
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 7,524
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 1,649
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 896
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,992
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 506
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,689
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 930
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 1,198
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,137
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 2,548
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 40
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 37
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 40
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 46
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 96
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 3,052
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 499
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 275
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 1,910
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 502
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 1,602
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 977
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 1,238
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 1,195
HTS_TST_POS <5, Unknown Sex, Positive 2019 28
HTS_TST_POS 10-14, Female, Positive 2019 4
HTS_TST_POS 10-14, Male, Positive 2019 2
HTS_TST_POS 15-19, Female, Positive 2019 1
HTS_TST_POS 15-19, Female, Positive 2019 4
HTS_TST_POS 20-24, Female, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 5
HTS_TST_POS 20-24, Male, Positive 2019 10
HTS_TST_POS 25-29, Female, Positive 2019 70
HTS_TST_POS 25-29, Female, Positive 2019 9
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 60
HTS_TST_POS 25-29, Female, Positive 2019 73
HTS_TST_POS 25-29, Female, Positive 2019 240
HTS_TST_POS 25-29, Female, Positive 2019 3
HTS_TST_POS 25-29, Female, Positive 2019 16
HTS_TST_POS 25-29, Female, Positive 2019 67
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 93
HTS_TST_POS 25-29, Male, Positive 2019 11
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 60
HTS_TST_POS 25-29, Male, Positive 2019 142
HTS_TST_POS 25-29, Male, Positive 2019 8
HTS_TST_POS 25-29, Male, Positive 2019 19
HTS_TST_POS 25-29, Male, Positive 2019 100
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 30-34, Female, Positive 2019 70
HTS_TST_POS 30-34, Female, Positive 2019 9
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 60
HTS_TST_POS 30-34, Female, Positive 2019 73
HTS_TST_POS 30-34, Female, Positive 2019 176
HTS_TST_POS 30-34, Female, Positive 2019 3
HTS_TST_POS 30-34, Female, Positive 2019 16
HTS_TST_POS 30-34, Female, Positive 2019 67
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 93
HTS_TST_POS 30-34, Male, Positive 2019 11
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 60
HTS_TST_POS 30-34, Male, Positive 2019 142
HTS_TST_POS 30-34, Male, Positive 2019 8
HTS_TST_POS 30-34, Male, Positive 2019 19
HTS_TST_POS 30-34, Male, Positive 2019 100
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 35-39, Female, Positive 2019 70
HTS_TST_POS 35-39, Female, Positive 2019 9
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 60
HTS_TST_POS 35-39, Female, Positive 2019 73
HTS_TST_POS 35-39, Female, Positive 2019 119
HTS_TST_POS 35-39, Female, Positive 2019 3
HTS_TST_POS 35-39, Female, Positive 2019 16
HTS_TST_POS 35-39, Female, Positive 2019 67
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Male, Positive 2019 93
HTS_TST_POS 35-39, Male, Positive 2019 11
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 60
HTS_TST_POS 35-39, Male, Positive 2019 142
HTS_TST_POS 35-39, Male, Positive 2019 8
HTS_TST_POS 35-39, Male, Positive 2019 19
HTS_TST_POS 35-39, Male, Positive 2019 100
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 70
HTS_TST_POS 40-49, Female, Positive 2019 9
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 60
HTS_TST_POS 40-49, Female, Positive 2019 73
HTS_TST_POS 40-49, Female, Positive 2019 60
HTS_TST_POS 40-49, Female, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 16
HTS_TST_POS 40-49, Female, Positive 2019 67
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Male, Positive 2019 95
HTS_TST_POS 40-49, Male, Positive 2019 11
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 60
HTS_TST_POS 40-49, Male, Positive 2019 142
HTS_TST_POS 40-49, Male, Positive 2019 8
HTS_TST_POS 40-49, Male, Positive 2019 19
HTS_TST_POS 40-49, Male, Positive 2019 100
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS 50+, Female, Positive 2019 10
HTS_TST_POS 50+, Male, Positive 2019 10
HTS_TST_POS By Key Population: FSW, Positive 2019 85
HTS_TST_POS By Key Population: MSM, Positive 2019 1
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 46
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 66
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 246
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 341
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 36
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 50
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 66
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 90
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 131
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 184
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 169
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 61
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 94
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 148
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 260
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 200
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 2,606
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 3,066
OVC_SERV Age/Sex: <1 2019 8
OVC_SERV Age/Sex: 1-9 2019 618
OVC_SERV Age/Sex: 10-14 Female 2019 604
OVC_SERV Age/Sex: 10-14 Male 2019 468
OVC_SERV Age/Sex: 15-17 Female 2019 463
OVC_SERV Age/Sex: 15-17 Male 2019 444
OVC_SERV By: Age/sex: 18-24 Female 2019 125
OVC_SERV By: Age/sex: Male 18-24 2019 76
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 2,806
OVC_SERV Program Completion: Active 2019 216
OVC_SERV Program Completion: Graduation 2,590 Number of orphans and vulnerable children (<18 years old) whose HIV status is known or unknown by the OVC implementing partner. 2,677 Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 2,806
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2019 7
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2019 13
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2019 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2019 7
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2019 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2019 6
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2019 21
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2019 16
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2019 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2019 8
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 25+ 2019 46
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 25+ 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2019 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2019 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2019 2
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2019 1
OVC_SERV Sum of Age/Sex disaggregates 2019 1,979
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,469
PMTCT_ART New on ART 2019 1,387
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 2,856
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,043
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 2,285
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 571
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 2,856
PMTCT_EID Sum of Infant Age disaggregates 2019 2,856
PMTCT_STAT 25-29, Female 2019 5,824
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 401
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 5,087
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 336
PMTCT_STAT 30-34, Female 2019 3,533
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 401
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 2,892
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 240
PMTCT_STAT 35-39, Female 2019 2,874
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 322
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2,348
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 204
PMTCT_STAT 40-49, Female 2019 1,960
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 63
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 1,650
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 247
PMTCT_STAT By Age (Numerator): 15-19 2019 22
PMTCT_STAT By Age (Numerator): 20-24 2019 3,830
PMTCT_STAT By Number of known positives: 20-24 2019 282
PMTCT_STAT By Number of new negative: 20-24 2019 3,210
PMTCT_STAT By Number of new positives: 15-19 2019 22
PMTCT_STAT By Number of new positives: 20-24 2019 338
PMTCT_STAT Number of new ANC and L&D clients 2019 19,208
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,043
PMTCT_STAT_den 25-29, Female 2019 3,533
PMTCT_STAT_den 30-34, Female 2019 2,874
PMTCT_STAT_den 35-39, Female 2019 2,874
PMTCT_STAT_den By Age (Denominator): <15-19 2019 3,830
PMTCT_STAT_den By Age (Denominator): 10-14 2019 22
PMTCT_STAT_den By Age (Denominator): 20-24 2019 6,072
PMTCT_STAT_den By Age (Denominator): 50+ 2019 3
PP_PREV 25-29, Female 2019 590
PP_PREV 25-29, Male 2019 246
PP_PREV 30-34, Female 2019 246
PP_PREV 30-34, Male 2019 246
PP_PREV 35-39, Female 2019 246
PP_PREV 35-39, Male 2019 246
PP_PREV 40-49, Female 2019 246
PP_PREV 40-49, Male 2019 244
PP_PREV Age/sex: 10-14 Female 2019 318
PP_PREV Age/sex: 10-14 Male 2019 311
PP_PREV Age/sex: 15-19 Female 2019 324
PP_PREV Age/sex: 15-19 Male 2019 311
PP_PREV Age/sex: 20-24 Female 2019 1,251
PP_PREV Age/sex: 20-24 Male 2019 607
PP_PREV Age/sex: 50+ Female 2019 38
PP_PREV Age/sex: 50+ Male 2019 30
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 5,500
PP_PREV Sum of Age/Sex disaggregates 2019 3,190
PrEP_NEW 25-29, Female 2019 97
PrEP_NEW 25-29, Male 2019 176
PrEP_NEW 30-34, Female 2019 146
PrEP_NEW 30-34, Male 2019 30
PrEP_NEW 35-39, Female 2019 30
PrEP_NEW 35-39, Male 2019 6
PrEP_NEW 40-49, Female 2019 6
PrEP_NEW Female 20-24 2019 97
PrEP_NEW FSW 2019 112
PrEP_NEW MSM 2019 73
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 588
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 48
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 627
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 37
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 435
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,178
TB_PREV By Age/Sex (Numerator): <15, Female 2019 35
TB_PREV By Age/Sex (Numerator): <15, Male 2019 12
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 434
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 456
TB_PREV IPT, Life-long ART, New, Positive 2019 937
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 937
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 1,561
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 34
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 32
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 869
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 626
TB_PREV_den IPT, Life-long ART, New, Positive 2019 1,561
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 27
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 677
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 22
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,111
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,837
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,837
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 27
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 677
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 22
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,111
TX_CURR 25-29, Female, Positive 2019 3,345
TX_CURR 25-29, Male, Positive 2019 1,471
TX_CURR 30-34, Female, Positive 2019 3,638
TX_CURR 30-34, Male, Positive 2019 2,329
TX_CURR 35-39, Female, Positive 2019 3,522
TX_CURR 35-39, Male, Positive 2019 2,497
TX_CURR 40-49, Female, Positive 2019 5,007
TX_CURR 40-49, Male, Positive 2019 5,032
TX_CURR Age/Sex: <1 2019 208
TX_CURR Age/Sex: <1-9 2019 481
TX_CURR Age/Sex: 10-14 Female 2019 463
TX_CURR Age/Sex: 10-14 Male 2019 267
TX_CURR Age/Sex: 15-19 Female 2019 1,080
TX_CURR Age/Sex: 15-19 Male 2019 669
TX_CURR Age/Sex: 20-24 Female 2019 1,886
TX_CURR Age/Sex: 20-24 Male 2019 637
TX_CURR Age/Sex: 50+ Female 2019 2,648
TX_CURR Age/Sex: 50+ Male 2019 2,311
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 37,496
TX_CURR Sum of age/sex disaggregates 2019 1,749
TX_NEW 25-29, Male, Positive 2019 24
TX_NEW 30-34, Female, Positive 2019 15
TX_NEW 30-34, Male, Positive 2019 60
TX_NEW 35-39, Female, Positive 2019 40
TX_NEW 35-39, Male, Positive 2019 72
TX_NEW 40-49, Female, Positive 2019 40
TX_NEW 40-49, Male, Positive 2019 127
TX_NEW Breastfeeding status 2019 517
TX_NEW By Age/Sex: 1-9 2019 224
TX_NEW By Age/Sex: 10-14 Male 2019 12
TX_NEW By Age/Sex: 15-19 Female 2019 59
TX_NEW By Age/Sex: 15-19 Male 2019 64
TX_NEW By Age/Sex: 20-24 Female 2019 32
TX_NEW By Age/Sex: 20-24 Male 2019 36
TX_NEW By Age/Sex: 50+ Female 2019 534
TX_NEW By Age/Sex: 50+ Male 2019 738
TX_NEW FSW 2019 65
TX_NEW MSM 2019 46
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 2,077
TX_NEW Pregnancy status 2019 519
TX_NEW Sum of Age/Sex disaggregates 2019 1,475
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 38,894
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 840
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 628
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 21,016
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 14,796
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 348
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 264
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 5,201
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,768
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 9,581
TX_RET Numerator by Status: Breastfeeding 2019 521
TX_RET Numerator by Status: Pregnant 2019 1,977
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 10,436
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 387
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 291
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,743
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 4,015
TX_RET_den Denominator by Status: Breastfeeding 2019 576
TX_RET_den Denominator by Status: Pregnant 2019 2,182
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 38,147
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 1,551
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,169
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 21,188
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 15,330
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 38,147
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 38,147
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 38,147
Cross Cutting Budget Categories and Known Amounts Total: $1,140,000
Gender: Gender Based Violence (GBV) $300,000
GBV Prevention
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation
Key Populations: Sex Workers $120,000
Monitoring and evaluation of SW programs
Collection and use of strategic information on SWs and clients
Key Populations: MSM and TG $30,000
Monitoring and evaluation of MSM/TG programs
Collection and use of strategic information
Human Resources for Health $500,000
Education $80,000
Food and Nutrition: Policy, Tools, and Service Delivery $110,000